Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment

Engineering & Materials Science

• Binding sites 65%
• Metabolites 63%
• Viruses 54%
• Crystal structure 19%
• Proteins 19%
• Administrative data processing 16%
• Immunization 7%
• Vaccines 7%

Medicine & Life Sciences

• GS-5734 100%
• Binding Sites 36%
• Viruses 31%
• Pharmaceutical Preparations 19%
• Adenosine Diphosphate Ribose 15%
• Adenosine Monophosphate 11%
• Therapeutics 7%
• Proteins 7%
• Coronavirus 6%
• Hospitalized Child 6%
• Mutation 5%
• United States Food and Drug Administration 5%

Chemical Compounds

• Metabolite 32%
• Binding Site 32%
• Drug 24%
• Mutation 19%
• Protein 19%
• Crystal Structure 17%